Verification of ceftriaxone and determination of its concentration in blood serum by capillary electrophoresis in surgical patients

A. Larichev, A. Smirnova, Natalya A. Slobodskaya, V. B. Kryuchkov, Andrey A. Vasiliev, Nikita M. Izyumov
{"title":"Verification of ceftriaxone and determination of its concentration in blood serum by capillary electrophoresis in surgical patients","authors":"A. Larichev, A. Smirnova, Natalya A. Slobodskaya, V. B. Kryuchkov, Andrey A. Vasiliev, Nikita M. Izyumov","doi":"10.21626/vestnik/2022-3/07","DOIUrl":null,"url":null,"abstract":"Objective: to develop a method for verifying ceftriaxone and determining its concentration in blood serum by means of capillary electrophoresis. Materials and methods. The study used ceftriaxone sodium salt (CJSC Pharmaceutical Company \"Lekko\"), model mixtures of biological fluids (whole blood, serum and blood plasma) with different concentrations of ceftriaxone; clinical biological blood samples taken during breast surgery against the background of perioperative antibiotic prophylaxis. The concentration of ceftriaxone was determined by using a Capel-105M capillary electrophoresis system (CJSC Lumex, St. Petersburg, Russia). Results. An express method has been developed for the determination of ceftriaxone in blood serum (sample volume - 0.1 ml), which involves the use of a precipitant of protein substances - crystalline ammonium sulfate, extraction of the organic system chloroform - isobutanol in a ratio of 3: 1, re-extraction of the substance into a working electrolyte diluted with water, and subsequent electrophoresis on the device \"Capel-105M\". Method validation indicates its linearity, correctness, precision and specificity; the lower limit of quantitation is 0.1 µg/0.1 ml biological medium. The effectiveness of the technique was confirmed in a clinical trial by determining the concentration of ceftriaxone in the blood serum 30 minutes after intravenous administration of 1 g of the drug for the purpose of perioperative antibiotic prophylaxis. Conclusion. The method for the quantitative determination of ceftriaxone in blood serum, performed by using a capillary electrophoresis system (“Kapel-105M”), meets the established validation criteria. At the same time, the identification of the antibiotic is carried out under selective conditions and requires a minimum amount of the object, thereby reducing the amount of co-extractive substances in the samples, which, in combination with the method of stacking during electrophoresis, provides a high sensitivity of the technique. It can be recommended for analysis in clinical diagnostic laboratories.","PeriodicalId":24060,"journal":{"name":"Курский научно-практический вестник «Человек и его здоровье»","volume":"16 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Курский научно-практический вестник «Человек и его здоровье»","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21626/vestnik/2022-3/07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: to develop a method for verifying ceftriaxone and determining its concentration in blood serum by means of capillary electrophoresis. Materials and methods. The study used ceftriaxone sodium salt (CJSC Pharmaceutical Company "Lekko"), model mixtures of biological fluids (whole blood, serum and blood plasma) with different concentrations of ceftriaxone; clinical biological blood samples taken during breast surgery against the background of perioperative antibiotic prophylaxis. The concentration of ceftriaxone was determined by using a Capel-105M capillary electrophoresis system (CJSC Lumex, St. Petersburg, Russia). Results. An express method has been developed for the determination of ceftriaxone in blood serum (sample volume - 0.1 ml), which involves the use of a precipitant of protein substances - crystalline ammonium sulfate, extraction of the organic system chloroform - isobutanol in a ratio of 3: 1, re-extraction of the substance into a working electrolyte diluted with water, and subsequent electrophoresis on the device "Capel-105M". Method validation indicates its linearity, correctness, precision and specificity; the lower limit of quantitation is 0.1 µg/0.1 ml biological medium. The effectiveness of the technique was confirmed in a clinical trial by determining the concentration of ceftriaxone in the blood serum 30 minutes after intravenous administration of 1 g of the drug for the purpose of perioperative antibiotic prophylaxis. Conclusion. The method for the quantitative determination of ceftriaxone in blood serum, performed by using a capillary electrophoresis system (“Kapel-105M”), meets the established validation criteria. At the same time, the identification of the antibiotic is carried out under selective conditions and requires a minimum amount of the object, thereby reducing the amount of co-extractive substances in the samples, which, in combination with the method of stacking during electrophoresis, provides a high sensitivity of the technique. It can be recommended for analysis in clinical diagnostic laboratories.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
头孢曲松在外科病人血清中的验证及毛细管电泳测定
目的:建立头孢曲松的毛细管电泳验证及血清浓度测定方法。材料和方法。该研究使用头孢曲松钠盐(CJSC制药公司“Lekko”),不同浓度头孢曲松的生物液体(全血、血清和血浆)模型混合物;以围手术期抗生素预防为背景,对乳房手术期间采集的临床生物血液样本进行分析。采用Capel-105M毛细管电泳系统(CJSC Lumex, St. Petersburg, Russia)测定头孢曲松浓度。结果。建立了一种快速测定血清中头孢曲松(样本量- 0.1 ml)的方法,该方法包括使用蛋白质物质沉淀剂-结晶硫酸铵,以3:1的比例提取有机系统氯仿-异丁醇,将该物质重新提取到用水稀释的工作电解质中,然后在“Capel-105M”设备上进行电泳。方法验证表明其线性、正确性、精密度和专属性;定量下限为0.1µg/0.1 ml生物培养基。该技术的有效性在临床试验中得到证实,通过静脉给药1g头孢曲松30分钟后测定血清中头孢曲松的浓度,用于围手术期抗生素预防。结论。采用毛细管电泳系统(“Kapel-105M”)定量测定血清中头孢曲松的方法符合既定的验证标准。同时,抗生素的鉴定是在选择性条件下进行的,需要最少的对象量,从而减少了样品中共萃取物质的量,与电泳时的堆叠方法相结合,提供了该技术的高灵敏度。它可以推荐用于临床诊断实验室的分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Determination of Mexidol in tablets by the method of derivative spectrophotometry Зонирование территорий исторических центров Уральских городов Phenotypic approach to personalization of pharmacotherapy in patients with congenetive heart failure with low left ventricular ejection fraction Development of a method for determining related impurities in a new biologically active compound of cardioprotective action by capillary electrophoresis Alliance of two pandemics: COVID-19 and diabetes mellitus
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1